Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Incorporating Sodium-glucose Cotransporter-2 Inhibitors to Regimens of Patients With Type 2 Diabetes

NCT06268977 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT06268977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06268977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Incorporating Sodium-glucose Cotransporter-2 Inhibitors to Regimens of Patients With Type 2 Diabetes
Lead sponsor
Assiut University
Phase
Phase 4
Overall status
Completed
Start date
April 1, 2025
Completion date
January 30, 2026
Enrollment
482 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes